Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs double standard dose trivalent inactivated influenza vaccine in peritoneal dialysis patients
TCTR20220526003Phase 3Unknown
- Sponsor
- Health Systems Research Institute
- Start
- Jul 2022
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of trivalent inactivated influenza vaccine in influenza (2 arms), sponsored by Health Systems Research Institute. Primary endpoint: Immunogenicity comparison between single and double dose. Status: unknown.
02
Drugs
trivalent inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on TCTR20220526003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220526003.